When was General Prognostics founded?

General Prognostics was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is General Prognostics located?

General Prognostics is headquartered in Boston, United States.

Who is the current CEO of General Prognostics?

Javier Echenique of General Prognostics. They have also founded 1 company.

How many employees does General Prognostics have?

As of Aug 31, 2026, the latest employee count at General Prognostics is 4.

Is General Prognostics a funded company?

General Prognostics is a funded company, having raised a total of $3.25M across 5 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Oct 29, 2020.

When was the latest funding round of General Prognostics?

General Prognostics' latest funding was a $***** Seed round on Nov 12, 2024, with participation from 1 investor.

Where does General Prognostics rank among its competitors?

General Prognostics ranks 44th amongst 556 active competitors, of which 118 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Respiree, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of General Prognostics?

General Prognostics' top competitors include AliveCor, iRhythm Tech and Vital Connect. Among them, Respiree secured the most recent funding round in September, 2026.

General Prognostics - 2026 Company Profile, Team, Funding & Competitors

General Prognostics is a seed company based in Boston (United States), founded in 2020 by Sidhant J, Javier Echenique and Sean Matsuoka. It operates as a Provider of AI-based health monitoring tools for healthcare professionals. General Prognostics has raised $3.25M in funding from D4V. The company has 556 active competitors, including 118 funded and 37 that have exited. Its top competitors include companies like AliveCor, iRhythm Tech and Vital Connect.

Company Details

Provider of AI-based health monitoring tools for healthcare professionals. The company has developed a biomarker-based remote monitoring solution for cardio-renal disease. It has featured blood analysis, remote monitoring analysis, and presymptomatic detection of critical patient conditions.

Website: gpx.ai
Social
Email ID: *****@generalprognostics.com

Key Metrics

Founded Year

2020

Location

Boston, United States

Stage

Seed

Total Funding

$3.25M in 5 rounds

Latest Funding Round

Seed, Nov 12, 2024, $*****

Investors

D4V & 7 more

Ranked

44^th among 556 active competitors

Employee Count

4 as on Aug 31, 2026

Similar Companies

iRhythm Tech & 690 more

View General Prognostics' full profile

General Prognostics has raised a total funding of $3.25M over 5 rounds. Its first funding round was on Oct 29, 2020. Its latest funding round was a Seed round on Nov 12, 2024 for $*****. 1 investor participated in its latest round. General Prognostics has 6 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of General Prognostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 12, 2024	2715021	Seed	4217989	8287156	9472430	1832754
Jun 28, 2024	8544891	Conventional Debt	4465494	5359408	7516992	6874842
Sep 30, 2022	6711975	Seed	9910014	8418537	D4V	Pete Moran & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of General Prognostics's funding rounds and investors

The founders of General Prognostics are Sidhant J, Javier Echenique and Sean Matsuoka. Javier Echenique is the CEO of General Prognostics.

Here are the details of General Prognostics' key team members:

Sidhant J: Co-Founder of General Prognostics and founder of 2 other companies, FaunaTech Solutions and Jana Care. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address
Javier Echenique: Co-Founder & CEO of General Prognostics and founder of 1 other company.
Contact Info: 2 email addresses
Sean Matsuoka: Co-Founder of General Prognostics and founder of 1 other company.
Contact Info: 2 email addresses

View details of General Prognostics's Founder profiles and Board Members

General Prognostics' employee count trend

General Prognostics has 4 employees as of Aug 26. Here is General Prognostics's employee count trend over the years:

Employee count trend for General Prognostics

Uncover General Prognostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of General Prognostics include AliveCor, iRhythm Tech and Vital Connect. Here is the list of Top 10 competitors of General Prognostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AliveCor 2010, Mountain View (United States), Series F	Developer of remote cardiac monitoring solutions and related analysis software	$114M	Mayo Clinic Business Accelerator, Khosla Ventures ... & 17 others	74/100
2nd	iRhythm Tech 2006, San Francisco (United States), Public	Provider of cloud-based cardiac rhythm monitoring devices	$98.9M	UNC Kenan-Flagler Private Equity, New Leaf Venture Partners ... & 12 others	73/100
3rd	Vital Connect 2011, Campbell (United States), Acquired	Developer of biosensor patch for body vitals monitoring	$240M	MVM, Ally Bridge Group & 9 others	66/100
4th	ZOLL AEDs 1983, Chelmsford (United States), Acquired	Developer of medical devices and software solutions for emergency care	-	Nobel Investments, Military Health & 2 others	64/100
5th	Welltory 2016, Redwood City (United States), Seed	Online health and wellness tracking and training platform	$1M	Braavo, Altair Capital & 6 others	63/100
6th	Biotricity 2014, San Francisco (United States), Public	Developer of medical remote monitoring solutions that help prevent and manage chronic diseases	-	SWK Holdings, National Research Council Canada ... & 2 others	63/100
7th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100
8th	Respiree 2018, Singapore (Singapore), Series A	Provider of AI and sensors-based post care solutions	$15M	Clavystbio, We Venture Capital & 22 others	60/100
9th	Lifesignals 2008, Milpitas (United States), Series C	Provider of AI‑driven wireless wearable biosensors for remote monitoring of patients	$15.7M	Lateral Capital, Seraph Group & 2 others	60/100
10th	Huinno 2015, New York City (United States), Series C	Developer of AI and cloud-based device for cardiac health monitoring and activity tracking	$47.6M	KTB Network, Shinhan Capital & 15 others	60/100
44th	General Prognostics 2020, Boston (United States), Seed	Provider of AI-based health monitoring tools for healthcare professionals	$3.25M	Plug and Play Tech Center, MIT Alumni Angels of Boston ... & 6 others	44/100